ストックスクリーナーアプリを入手
40.15
0.75%
0.30
アフターアワーズ：
40.15
Qiagen Nv (QGEN) 最新ニュース
QIAGEN N.V. Files 2024 Annual Report with SEC - TipRanks
QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results - DutchNews.nl
PTA-CMS: QIAGEN N.V.: Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] - TradingView
QIAGEN Releases Full 2024 Annual Report: Access Complete Financial Data and Analysis - Stock Titan
Are Qiagen N.V.'s (NYSE:QGEN) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market? - Yahoo Finance
QIAGEN NV : Jefferies reiterates its Buy rating - Marketscreener.com
Qiagen N.V. (NYSE:QGEN) is a favorite amongst institutional investors who own 81% - simplywall.st
Qiagen Manager Pledges Shares in Securities Lending Transaction - TipRanks
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
QGEN Stock Might Rise Following Partnership With Genomics England - MSN
Is it Worth Retaining QIAGEN Stock in Your Portfolio Now? - Yahoo Finance
Digital Genome Market to Witness Remarkable Growth with QIAGEN, GenomeMe Inc., NanoString Technologies - openPR
The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses - Yahoo Finance
Qiagen (QGEN) Down 6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
FDA clears Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B - Medical Device Network
Qiagen at TD Cowen Conference: Strategic Growth Plans Unveiled - Investing.com
Sector Update: Health Care Stocks Flat to Lower Premarket Thursday -March 06, 2025 at 09:14 am EST - Marketscreener.com
Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection - GlobeNewswire Inc.
QIAGEN Gets US FDA Clearance for Second QIAstat-Dx Mini Gastrointestinal Panel -March 06, 2025 at 04:04 am EST - MarketScreener
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio - Silicon Canals
Market is not liking Qiagen's (NYSE:QGEN) earnings decline as stock retreats 4.7% this week - Simply Wall St
Analyzing Tevogen Bio (NASDAQ:TVGN) and Qiagen (NYSE:QGEN) - Defense World
QIAGEN Announces Managerial Transactions Involving Performance Stock Units - TipRanks
QIAGEN Announces Managerial Stock Transaction - TipRanks
Qiagen Announces Managerial Stock Unit Grant - TipRanks
Qiagen Announces Managerial Stock Transactions - TipRanks
Qiagen Announces Managerial Transaction Involving Restricted Stock Units - TipRanks
Qiagen N.V. (QGEN): Among the Cash-Rich Mid Cap Stocks to Buy Now - MSN
Relative Strength Alert For Qiagen - Nasdaq
10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey
BioMérieux: complaint lodged by German company Qiagen -March 03, 2025 at 05:57 am EST - Marketscreener.com
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing - sharewise
Qiagen Files Patent Infringement Complaint in Germany Against bioMerieux -March 03, 2025 at 05:02 am EST - Marketscreener.com
How QIAGEN's Patent Lawsuit Against bioMérieux Could Reshape the TB Testing Market - Stock Titan
What is Zacks Research’s Estimate for Qiagen Q1 Earnings? - Defense World
QIAGEN Files Patent Complaint Against BioMérieux To Protect QuantiFERON Technology - Nasdaq
Qiagen Takes Legal Action To Defend Quantiferon Intellectual Property -March 03, 2025 at 01:04 am EST - Marketscreener.com
Zacks Research Issues Negative Estimate for Qiagen Earnings - Defense World
Zacks Research Forecasts Qiagen's Q4 Earnings (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Reaches New 12-Month LowWhat's Next? - MarketBeat
Qiagen (NYSE:QGEN) Receives Average Rating of “Hold” from Brokerages - Defense World
Qiagen stock touches 52-week low at $38.48 amid market shifts - Investing.com
Qiagen stock touches 52-week low at $38.48 amid market shifts By Investing.com - Investing.com South Africa
Qiagen N.V.: Some Clarity Needed Before Buying The Dip (NYSE:QGEN) - Seeking Alpha
Genetic Testing Market Future Business Opportunities - openPR
AlphaValue/Baader Europe Upgrades Qiagen to Buy, Trims PT -February 24, 2025 at 07:17 am EST - Marketscreener.com
Qiagen (NYSE:QGEN) Stock Rating Lowered by Baird R W - MarketBeat
Qiagen (NYSE:QGEN) Reaches New 1-Year LowHere's What Happened - MarketBeat
Qiagen (NYSE:QGEN) Rating Lowered to Neutral at Robert W. Baird - MarketBeat
Qiagen, Bio-Techne downgraded at Baird amid NIH funding concerns - MSN
QIAGEN NV : Berenberg remains its Buy rating -February 21, 2025 at 03:41 am EST - Marketscreener.com
QIAGEN-TCS 10-year Partnership Accelerates Digital Transformation - Tata Consultancy Services (TCS)
Baird Downgrades Qiagen N.V. (BIT:1QGEN) - Nasdaq
1.12%
1.76%
大文字化:
|
ボリューム (24 時間):